Company Quick10K Filing
Quick10K
Healthcare Trust
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-09-06 Regulation FD, Exhibits
8-K 2019-08-20 Other Events, Exhibits
8-K 2019-07-29 Officers
8-K 2019-07-25 Enter Agreement, Exhibits
8-K 2019-07-22 Other Events, Exhibits
8-K 2019-05-30 Regulation FD, Exhibits
8-K 2019-05-10 Shareholder Vote
8-K 2019-05-06 Other Events
8-K 2019-04-01 Other Events
8-K 2019-03-26 Other Events, Exhibits
8-K 2019-03-26 Regulation FD, Exhibits
8-K 2019-03-14 Accountant, Exhibits
8-K 2019-01-28 Other Events, Exhibits
8-K 2018-12-04 Regulation FD, Exhibits
8-K 2018-09-05 Regulation FD, Exhibits
8-K 2018-08-28 Regulation FD, Exhibits
8-K 2018-08-23 Officers
8-K 2018-06-29 Other Events
8-K 2018-06-06 Regulation FD, Exhibits
8-K 2018-05-31 Shareholder Vote
8-K 2018-04-10 Enter Agreement, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2018-04-03 Regulation FD, Exhibits
8-K 2018-03-29 Other Events
8-K 2018-03-13 Other Events, Exhibits
8-K 2018-03-02 Off-BS Arrangement
8-K 2018-02-20 Other Events
8-K 2017-12-28 Enter Agreement, Off-BS Arrangement, Exhibits

Healthcare Trust Financials

-

HCT Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comparables ($MM Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Ryanair Holdings RYAA -0 13,251 8,036 0 0 0 0 -35
Lingo Media LMDC -0 1 1 0 0 0 0 -0
Apollo Education APOL 1,063 1,955 886 2,000 0 -20 63 579
China Crawfish CACA -0 0 0 0 0 -0 -0 -0
Mirenco MREO
Granite Real Estate GRP
Weyland Tech WEYL -0 11 5 29 -1 -4 -4 -5
Baynon BNON -0 0 0 0 0 -0 -0 0
Green Planet Bio Engineering GPLB 3 0 0 0 0 -0 -0 3
G-Mes Holdings GMES -0 1 1 1 1 0 0 -0
Immune Therapeutics IMUN 0 0 13 0 0 -5 -5 -0
Therapeutic Solutions TSOI 0 0 2 0 0 -2 -1 0
Blue Sphere BLSP 1 44 87 8 3 -14 -14 9
Frontier Digital Media Group FDMG -0 0 0 0 0 -0 -0 -0
Stem Holdings STEMH -0 41 6 1 0 -8 -7 -5
MWF Global MWF -0 -0 -0 0 0 -0 -0 -0
Clean Coal Technologies CCTC -0 0 17 0 0 -6 -3 1
SpringWorks SWTX
Brighthouse Life Insurance Co of Ny BHNY -0 9,066 8,030 237 0 0 3 -190
Imine JRVS 6 0 1 0 0 -2 -2 6

Balance Sheet ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash01738112406964766183991094824374150299215867103718669917965
Accounts Receivable
Inventory
PP&E74245631829951,6321,7351,8161,8982,1952,1772,1502,1192,1142,0602,0582,0652,1762,1762,1722,1332,1712,1852,170
Assets026811604821,1941,8111,8581,8761,9821,9942,2722,2662,2402,2202,1942,2412,3082,2262,3722,3482,3652,3512,3772,3452,330
Accounts Payable
Long-Term Debt
Liabilities1112576971261673063566706846796886897918808461,0161,0171,0531,0831,1371,1241,149
Stockholders' Equity-125801584771,1181,7141,7221,6991,6661,6281,5921,5731,5521,5231,4951,4421,4201,3721,3481,3231,3041,2601,2331,2141,175
Income Statement ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue0011131242576064667676767675767982899190928996
Cost of Revenue427293439414443444851535459555359
Gross Profit830313137353232313131363731373637
R&D
SG&A
Tax-010-0-00-10-0-00-0000000
Net Income-0-0-00-1-4-20-13-5-13-16-7-2-3-9-8-6-5-24-8-6-7-30-10-5-6
Cash Flow ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating0-0-0-11-0-11525171592622161917111717111116179
Cash Investing-35-4-21-68-826-616-90-113-100-255-1045-5-16-44-129-21-18-41-3510-15
Cash Financing024567931462663927-1910723222-4-22-124866-58144-27221441-40-7